Clinical Trials Directory

Trials / Completed

CompletedNCT06232967

PPIO-006 Primary Tumor Resection for IVa NSCLC

Long-term Outcome of Primary Tumor Resection in Non-Small-Cell Lung Cancer Patients With Dry Pleural Dissemination: A Multi-center Study

Status
Completed
Phase
Study type
Observational
Enrollment
223 (actual)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this mutli-center observational study is toinvestigate the impact of primary tumor resection (PTR) on the long-term survival of patients with non-small-cell lung cancer (NSCLC) and dry pleural dissemination (DPD). The main question it aims to answer is: whether primary tumor resection improve long-term survival of NSCLC patients with dry pleural dissemination.

Detailed description

Non-small-cell lung cancer (NSCLC) patients with dry pleural dissemination have poor survival rates and are generally contraindicated for surgery. Previous single-center retrospective studies have suggested that these patients may benefit from primary tumor resection (PTR). However, the evidence supporting PTR is still limited, especially in the era of targeted therapy. This study aimed to investigate the impact of PTR on the long-term survival of patients with NSCLC and DPD.

Conditions

Interventions

TypeNameDescription
PROCEDUREPrimary tumor resection or notFor patients with non-small-cell lung cancer (NSCLC) and dry pleural dissemination, surgical decisions to perform exploratory thoracotomy only or primary tumor resection with wedge resection, segmentectomy, or lobectomy were based on surgeon experience and patient preference.

Timeline

Start date
2023-04-01
Primary completion
2023-10-30
Completion
2023-12-30
First posted
2024-01-31
Last updated
2024-06-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06232967. Inclusion in this directory is not an endorsement.